Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05008744 · ClinicalTrials.gov registry record

Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome

A clinical trial of Monochorionic Diamniotic Placenta and Twin to Twin Transfusion as Antepartum Condition, sponsored by Seattle Children's Hospital.

Recruiting
Registry status
2,000
Enrollment target
2
Study locations

NCT05008744: Recruiting study of Monochorionic Diamniotic Placenta and Twin to Twin Transfusion as Antepartum Condition, sponsored by Seattle Children's Hospital.

NCT05008744 is a study of Monochorionic Diamniotic Placenta and Twin to Twin Transfusion as Antepartum Condition that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 2,000 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05008744, a study of Monochorionic Diamniotic Placenta and Twin to Twin Transfusion as Antepartum Condition, is actively recruiting participants, sponsored by Seattle Children's Hospital.

RECRUITING
Registry status
2,000 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to evaluate the use of diode laser photocoagulation of the communicating vessels in twin-to- twin transfusion syndrome (TTTS) with respect to maternal, fetal and neonatal outcomes.

Interventions

  • PROCEDURE Fetoscopic laser ablation

Study Locations (2)

Washington

  • Seattle Childrens Hospital - Seattle
  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2021-10-01
Est. Completion 2031-10-01

Sponsor

Seattle Children's Hospital

168 total trials

What the Registry Record Tells You About NCT05008744

The ClinicalTrials.gov registry entry for NCT05008744 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Monochorionic Diamniotic Placenta appearing as the primary indexed condition, and to 1 intervention - of which Fetoscopic laser ablation is the first listed.

NCT05008744 reports 2 study locations spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT05008744 about?

NCT05008744 is a clinical study titled "Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome". The purpose of this study is to evaluate the use of diode laser photocoagulation of the communicating vessels in twin-to- twin transfusion syndrome (TTTS) with respect to maternal, fetal and neonatal outcomes.

What is the current status of trial NCT05008744?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2021-10-01. Estimated completion is 2031-10-01.

What conditions does trial NCT05008744 study?

This clinical trial studies the following conditions: Monochorionic Diamniotic Placenta, Twin to Twin Transfusion as Antepartum Condition.

What interventions are being tested in trial NCT05008744?

The interventions under investigation include: Fetoscopic laser ablation (PROCEDURE).

Who is sponsoring clinical trial NCT05008744?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05008744 being conducted?

This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Monochorionic Diamniotic Placenta

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.